Recombinant Human (EGF) Market is Estimated To Witness High Growth...

added article Health

2023-11-27 08:14:18 -

Recombinant Human (EGF) Market is Estimated To Witness High Growth Owing To Increasing Demand from Biopharmaceutical Industry

The recombinant human (EGF) market is estimated to be valued at US$ 12246.47 Mn in 2023 and is expected to exhibit a CAGR of 9.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. The recombinant human (EGF) market is estimated to be valued at US$ 12246.47 Mn in 2023 and is expected to exhibit a CAGR of 9.3% over the forecast period...

0 Comments 0 Shares 1072 Views 0 Reviews